- call +1-201-465-4211
- email sales@mrinsights.biz
Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most Cushing's syndrome cases are caused by pituitary adenoma, and multiple endocrine neoplasia. Acromegaly involves symptoms such as enlargement of the hands, feet, forehead, jaw, nose etc. resulting in joint pain, thickening of skin, deepening of the voice, headaches, and vision problems. Other complications include type 2 diabetes, and hypertension. Acromegaly is also caused by production of excess growth hormone (GH). Most cases of Acromegaly is due to the pituitary gland producing excessive growth hormone mostly due a benign tumor, known as a pituitary adenoma.
Scope of the Report:
In terms of value, North America is expected to be the dominant regional market for Cushing’s Syndrome and Acromegaly treatment by 2025 and is expected to expand at a CAGR of 9% over the forecast period.
The global Cushing's Syndrome and Acromegaly Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cushing's Syndrome and Acromegaly Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Cushing's Syndrome and Acromegaly Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cushing's Syndrome and Acromegaly Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
Pfizer
Novartis
Bristol-Myers Squibb
Corcept Therapeutics
HRA Pharma
Ipsen Biopharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Glucocorticoid Receptor Inhibitors
Somatostatin
Ketoconazole HRA
Others
Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Cushing's Syndrome and Acromegaly Treatment Market Overview
1.1 Product Overview and Scope of Cushing's Syndrome and Acromegaly Treatment
1.2 Classification of Cushing's Syndrome and Acromegaly Treatment by Types
1.2.1 Global Cushing's Syndrome and Acromegaly Treatment Revenue Comparison by Types (2017-2023)
1.2.2 Global Cushing's Syndrome and Acromegaly Treatment Revenue Market Share by Types in 2017
1.2.3 Glucocorticoid Receptor Inhibitors
1.2.4 Somatostatin
1.2.5 Ketoconazole HRA
1.2.6 Others
1.3 Global Cushing's Syndrome and Acromegaly Treatment Market by Application
1.3.1 Global Cushing's Syndrome and Acromegaly Treatment Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Cushing's Syndrome and Acromegaly Treatment Market by Regions
1.4.1 Global Cushing's Syndrome and Acromegaly Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Cushing's Syndrome and Acromegaly Treatment Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cushing's Syndrome and Acromegaly Treatment Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cushing's Syndrome and Acromegaly Treatment Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Cushing's Syndrome and Acromegaly Treatment Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cushing's Syndrome and Acromegaly Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Cushing's Syndrome and Acromegaly Treatment (2013-2023)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Cushing's Syndrome and Acromegaly Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Cushing's Syndrome and Acromegaly Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Cushing's Syndrome and Acromegaly Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis Cushing's Syndrome and Acromegaly Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bristol-Myers Squibb
2.3.1 Business Overview
2.3.2 Cushing's Syndrome and Acromegaly Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bristol-Myers Squibb Cushing's Syndrome and Acromegaly Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Corcept Therapeutics
2.4.1 Business Overview
2.4.2 Cushing's Syndrome and Acromegaly Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Corcept Therapeutics Cushing's Syndrome and Acromegaly Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 HRA Pharma
2.5.1 Business Overview
2.5.2 Cushing's Syndrome and Acromegaly Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 HRA Pharma Cushing's Syndrome and Acromegaly Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 Ipsen Biopharmaceuticals
2.6.1 Business Overview
2.6.2 Cushing's Syndrome and Acromegaly Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Ipsen Biopharmaceuticals Cushing's Syndrome and Acromegaly Treatment Revenue, Gross Margin and Market Share (2016-2017)
3 Global Cushing's Syndrome and Acromegaly Treatment Market Competition, by Players
3.1 Global Cushing's Syndrome and Acromegaly Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Cushing's Syndrome and Acromegaly Treatment Players Market Share
3.2.2 Top 10 Cushing's Syndrome and Acromegaly Treatment Players Market Share
3.3 Market Competition Trend
4 Global Cushing's Syndrome and Acromegaly Treatment Market Size by Regions
4.1 Global Cushing's Syndrome and Acromegaly Treatment Revenue and Market Share by Regions
4.2 North America Cushing's Syndrome and Acromegaly Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Cushing's Syndrome and Acromegaly Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Cushing's Syndrome and Acromegaly Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Cushing's Syndrome and Acromegaly Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Cushing's Syndrome and Acromegaly Treatment Revenue and Growth Rate (2013-2018)
5 North America Cushing's Syndrome and Acromegaly Treatment Revenue by Countries
5.1 North America Cushing's Syndrome and Acromegaly Treatment Revenue by Countries (2013-2018)
5.2 USA Cushing's Syndrome and Acromegaly Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Cushing's Syndrome and Acromegaly Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Cushing's Syndrome and Acromegaly Treatment Revenue and Growth Rate (2013-2018)
6 Europe Cushing's Syndrome and Acromegaly Treatment Revenue by Countries
6.1 Europe Cushing's Syndrome and Acromegaly Treatment Revenue by Countries (2013-2018)
6.2 Germany Cushing's Syndrome and Acromegaly Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Cushing's Syndrome and Acromegaly Treatment Revenue and Growth Rate (2013-2018)
6.4 France Cushing's Syndrome and Acromegaly Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Cushing's Syndrome and Acromegaly Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Cushing's Syndrome and Acromegaly Treatment Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Cushing's Syndrome and Acromegaly Treatment Revenue by Countries
7.1 Asia-Pacific Cushing's Syndrome and Acromegaly Treatment Revenue by Countries (2013-2018)
7.2 China Cushing's Syndrome and Acromegaly Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Cushing's Syndrome and Acromegaly Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Cushing's Syndrome and Acromegaly Treatment Revenue and Growth Rate (2013-2018)
7.5 India Cushing's Syndrome and Acromegaly Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Cushing's Syndrome and Acromegaly Treatment Revenue and Growth Rate (2013-2018)
8 South America Cushing's Syndrome and Acromegaly Treatment Revenue by Countries
8.1 South America Cushing's Syndrome and Acromegaly Treatment Revenue by Countries (2013-2018)
8.2 Brazil Cushing's Syndrome and Acromegaly Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Cushing's Syndrome and Acromegaly Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Cushing's Syndrome and Acromegaly Treatment Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Cushing's Syndrome and Acromegaly Treatment by Countries
9.1 Middle East and Africa Cushing's Syndrome and Acromegaly Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Cushing's Syndrome and Acromegaly Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Cushing's Syndrome and Acromegaly Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Cushing's Syndrome and Acromegaly Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Cushing's Syndrome and Acromegaly Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Cushing's Syndrome and Acromegaly Treatment Revenue and Growth Rate (2013-2018)
10 Global Cushing's Syndrome and Acromegaly Treatment Market Segment by Type
10.1 Global Cushing's Syndrome and Acromegaly Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Cushing's Syndrome and Acromegaly Treatment Market Forecast by Type (2018-2023)
10.3 Glucocorticoid Receptor Inhibitors Revenue Growth Rate (2013-2023)
10.4 Somatostatin Revenue Growth Rate (2013-2023)
10.5 Ketoconazole HRA Revenue Growth Rate (2013-2023)
10.6 Others Revenue Growth Rate (2013-2023)
11 Global Cushing's Syndrome and Acromegaly Treatment Market Segment by Application
11.1 Global Cushing's Syndrome and Acromegaly Treatment Revenue Market Share by Application (2013-2018)
11.2 Cushing's Syndrome and Acromegaly Treatment Market Forecast by Application (2018-2023)
11.3 Hospital Pharmacies Revenue Growth (2013-2018)
11.4 Retail Pharmacies Revenue Growth (2013-2018)
11.5 Online Pharmacies Revenue Growth (2013-2018)
12 Global Cushing's Syndrome and Acromegaly Treatment Market Size Forecast (2018-2023)
12.1 Global Cushing's Syndrome and Acromegaly Treatment Market Size Forecast (2018-2023)
12.2 Global Cushing's Syndrome and Acromegaly Treatment Market Forecast by Regions (2018-2023)
12.3 North America Cushing's Syndrome and Acromegaly Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Cushing's Syndrome and Acromegaly Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Cushing's Syndrome and Acromegaly Treatment Revenue Market Forecast (2018-2023)
12.6 South America Cushing's Syndrome and Acromegaly Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Cushing's Syndrome and Acromegaly Treatment Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Cushing's Syndrome and Acromegaly Treatment Picture
Table Product Specifications of Cushing's Syndrome and Acromegaly Treatment
Table Global Cushing's Syndrome and A
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
